Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 92,930,114
- Total 13F shares
- 72,978,794
- Share change
- +1,941,256
- Total reported value
- $1,535,405,782
- Put/Call ratio
- 115%
- Price per share
- $21.03
- Number of holders
- 153
- Value change
- +$36,464,951
- Number of buys
- 83
- Number of sells
- 80
Report period
Q4 2022
Institutions
153
Top holders
10
TVTX full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89422G107
Recent filing periods:
Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
6.3%
|
5,836,000
|
$143,799,000 | — | 30 Sep 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.3%
|
4,922,941
|
$121,301,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.9%
|
4,564,750
|
$112,476,000 | — | 30 Sep 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
4.3%
|
4,000,000
|
$98,560,000 | — | 30 Sep 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.2%
|
3,912,485
|
$96,401,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
3,413,415
|
$84,107,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
3,381,610
|
$83,323,000 | — | 30 Sep 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.6%
|
3,310,256
|
$81,585,000 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.6%
|
3,300,009
|
$81,312,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.7%
|
2,553,974
|
$62,930,000 | — | 30 Sep 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.5%
|
2,350,000
|
$57,904,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
1,507,422
|
$37,143,000 | — | 30 Sep 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.3%
|
1,253,130
|
$30,877,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
1,099,690
|
$27,097,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,060,406
|
$26,128,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
1,057,003
|
$26,044,000 | — | 30 Sep 2022 | |
| Finepoint Capital LP |
13F
|
Company |
1.1%
|
1,028,875
|
$25,351,000 | — | 30 Sep 2022 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1%
|
966,108
|
$23,805,000 | — | 30 Sep 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1%
|
951,650
|
$23,449,000 | — | 30 Sep 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.99%
|
924,514
|
$22,780,000 | — | 30 Sep 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
0.9%
|
834,961
|
$20,573,000 | — | 30 Sep 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.81%
|
756,000
|
$18,628,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.78%
|
728,114
|
$17,941,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
632,145
|
$15,576,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.64%
|
598,999
|
$14,759,000 | — | 30 Sep 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.59%
|
543,789
|
$13,398,961 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.57%
|
530,091
|
$13,061,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
462,842
|
$11,405,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.47%
|
437,586
|
$10,783,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
433,417
|
$10,680,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0.45%
|
418,905
|
$10,322,000 | — | 30 Sep 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.45%
|
416,729
|
$10,268,000 | — | 30 Sep 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.44%
|
412,511
|
$10,164,000 | — | 30 Sep 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.44%
|
411,618
|
$10,143,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.44%
|
409,488
|
$10,098,000 | — | 30 Sep 2022 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.42%
|
394,678
|
$9,725,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.4%
|
375,843
|
$9,261,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.4%
|
373,068
|
$9,192,000 | — | 30 Sep 2022 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.37%
|
342,290
|
$8,434,000 | — | 30 Sep 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.36%
|
338,424
|
$8,339,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.35%
|
327,833
|
$8,077,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.35%
|
327,706
|
$8,075,000 | — | 30 Sep 2022 | |
| AXA S.A. |
13F
|
Company |
0.3%
|
276,497
|
$6,812,886 | — | 30 Sep 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.3%
|
276,460
|
$6,812,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.29%
|
268,175
|
$6,608,000 | — | 30 Sep 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
249,700
|
$6,153,000 | — | 30 Sep 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.27%
|
247,678
|
$6,103,000 | — | 30 Sep 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.27%
|
246,849
|
$6,082,000 | — | 30 Sep 2022 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.26%
|
243,838
|
$6,008,000 | — | 30 Sep 2022 | |
| NORGES BANK |
13F
|
Company |
0.25%
|
235,900
|
$5,812,576 | — | 30 Sep 2022 |
Institutional Holders of Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) as of Q4 2022
As of 31 Dec 2022,
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,978,794 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., MACQUARIE GROUP LTD, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
153
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
168
Q4 2022 holders
153
Holder diff
-15
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.